These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7674941)

  • 1. Tissue inhibitors of matrix metalloendopeptidases.
    Murphy G; Willenbrock F
    Methods Enzymol; 1995; 248():496-510. PubMed ID: 7674941
    [No Abstract]   [Full Text] [Related]  

  • 2. Secreted inhibitors of mammalian metalloproteinases.
    Banda MJ; Howard EW
    Ann N Y Acad Sci; 1991; 624():109-15. PubMed ID: 1648322
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitor.
    Murphy G
    Matrix Suppl; 1992; 1():323-4. PubMed ID: 1480052
    [No Abstract]   [Full Text] [Related]  

  • 4. A Mr 21,000 inhibitor of matrix metalloproteinases from human fibroblasts.
    Moore WG; Birkedal-Hansen B; Pierson M; Birkedal-Hansen H
    Matrix Suppl; 1992; 1():319-20. PubMed ID: 1480050
    [No Abstract]   [Full Text] [Related]  

  • 5. The regulation of connective tissue metalloproteinases by natural inhibitors.
    Murphy G
    Agents Actions Suppl; 1991; 35():69-76. PubMed ID: 1781423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of matrix metalloproteinase activity.
    Murphy G; Willenbrock F; Crabbe T; O'Shea M; Ward R; Atkinson S; O'Connell J; Docherty A
    Ann N Y Acad Sci; 1994 Sep; 732():31-41. PubMed ID: 7978800
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation and characterization of tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) from human rheumatoid synovial fluid.
    Osthues A; Knäuper V; Oberhoff R; Reinke H; Tschesche H
    FEBS Lett; 1992 Jan; 296(1):16-20. PubMed ID: 1730286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of TIMP and MMP inhibition in preventing connective tissue breakdown.
    Cawston T; Plumpton T; Curry V; Ellis A; Powell L
    Ann N Y Acad Sci; 1994 Sep; 732():75-83. PubMed ID: 7978853
    [No Abstract]   [Full Text] [Related]  

  • 9. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
    Dittmann KH; Lottspeich F; Ries C; Petrides PE
    Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1.
    Ward RV; Hembry RM; Reynolds JJ; Murphy G
    Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):179-87. PubMed ID: 1909113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite.
    Frears ER; Zhang Z; Blake DR; O'Connell JP; Winyard PG
    FEBS Lett; 1996 Feb; 381(1-2):21-4. PubMed ID: 8641430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity.
    Murphy G; Houbrechts A; Cockett MI; Williamson RA; O'Shea M; Docherty AJ
    Biochemistry; 1991 Aug; 30(33):8097-102. PubMed ID: 1868085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A.
    Willenbrock F; Crabbe T; Slocombe PM; Sutton CW; Docherty AJ; Cockett MI; O'Shea M; Brocklehurst K; Phillips IR; Murphy G
    Biochemistry; 1993 Apr; 32(16):4330-7. PubMed ID: 8476862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding of gelatinases A and B to type I collagen yields both high and low affinity sites.
    Allan JA; Docherty AJ; Murphy G
    Ann N Y Acad Sci; 1994 Sep; 732():365-6. PubMed ID: 7978809
    [No Abstract]   [Full Text] [Related]  

  • 15. HL-60 leukemia cells produce an autocatalytically truncated form of matrix metalloproteinase-9 with impaired sensitivity to inhibition by tissue inhibitors of metalloproteinases.
    Ries C; Lottspeich F; Dittmann KH; Petrides PE
    Leukemia; 1996 Sep; 10(9):1520-6. PubMed ID: 8751473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2.
    Sato H; Kinoshita T; Takino T; Nakayama K; Seiki M
    FEBS Lett; 1996 Sep; 393(1):101-4. PubMed ID: 8804434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human stromelysin by peptides based on the N-terminal domain of tissue inhibitor of metalloproteinases-1.
    Hanglow AC; Lugo A; Walsky R; Visnick M; Coffey JW; Fotouhi N
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1156-63. PubMed ID: 7802645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins.
    Docherty AJ; Murphy G
    Ann Rheum Dis; 1990 Jun; 49 Suppl 1():469-79. PubMed ID: 2197998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis.
    Ray JM; Stetler-Stevenson WG
    Eur Respir J; 1994 Nov; 7(11):2062-72. PubMed ID: 7533104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secreted inhibitors of metalloproteinases (IMPs) that are distinct from TIMP.
    Banda MJ; Howard EW; Herron GS; Apodaca G
    Matrix Suppl; 1992; 1():294-8. PubMed ID: 1480040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.